drugset / Trial / NCT00150384

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

NCT00150384

Phase 4 Completed 500 enrolled Viatris Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

Timeline

Start
2004-07
Primary completion
Completion
2005-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Atorvastatin Small molecule